Clinical effect of obesity on N-terminal pro-B-type natriuretic peptide cut-off concentrations for the diagnosis of acute heart failure,European Journal of Heart Failure

当前位置： X-MOL 学术 › Eur. J. Heart Fail. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Clinical effect of obesity on N-terminal pro-B-type natriuretic peptide cut-off concentrations for the diagnosis of acute heart failure
European Journal of Heart Failure ( IF 16.9 ) Pub Date : 2022-07-18 , DOI: 10.1002/ejhf.2618
Nikola Kozhuharov _{1,

2} , Jasmin Martin _{1,

3} , Desiree Wussler _{1,

3} , Pedro Lopez-Ayala _{1,

3} , Maria Belkin _{1,

3} , Ivo Strebel ₁ , Dayana Flores ₁ , Matthias Diebold _{1,

3} , Samyut Shrestha _{1,

3} , Albina Nowak ₄ , Danielle M Gualandro ₁ , Eleni Michou ₁ , Tobias Zimmermann _{1,

3,

5} , Katharina Rentsch ₆ , Arnold von Eckardstein ₇ , Dagmar I Keller ₈ , Tobias Breidthardt _{1,

3} , Christian Mueller ₁ ,

Affiliation

Obese patients have lower natriuretic peptide concentrations. We hypothesized that adjusting the concentration of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for obesity could further increase its clinical utility in the early diagnosis of acute heart failure (AHF).

中文翻译：